The quadrivalent HPV vaccine provides durable immune responses and protects against cervical disease in women with HIV.

Updated recommendations were presented for the management of UTIs in infants and children younger than 5 years in a recent guideline.

Congenital TORCH infections appear to be associated with an increased risk for intellectual disability and autism.

Compared with men, women with autoimmune disease are more likely to have longer delays to diagnosis and to have misdiagnoses.

Two respiratory syncytial virus (RSV) vaccines, RSVPreF3+AS01 and RSVpreF, were highly effective at preventing hospital admissions and death among older adults during the 2023 to 2024 season. These ...

The FDA has approved Hovilpri for immunocompromised adults with refractory mucocutaneous HSV lesions, offering a novel oral treatment.

Topline phase 3 OPUS-1 data show VAX-31 met coprimary immunogenicity endpoints, demonstrating noninferiority and superiority for key pneumococcal serotypes.

The M72/AS01 TB vaccine was safe for virologically suppressed adults with HIV, with no severe vaccine-related AEs reported.

Adults hospitalized with CAP face high mortality rates, particularly those with unsuppressed HIV and tuberculosis.

People with HIV experience a significantly greater increase in multimorbidity following COVID-19 diagnosis compared with those without HIV.

An MF59-adjuvanted, higher-dose influenza vaccine improves immune responses in older adults compared with standard egg-based options.

Meningitis incidence and mortality declined significantly in the Western Pacific Region from 1990 to 2023 following expanded vaccination initiatives.